Status:
RECRUITING
Mechanisms and Interventions of Social Reward on Cognitive Control in Internet Gaming Disorder
Lead Sponsor:
The First Affiliated Hospital of Bengbu Medical University
Collaborating Sponsors:
Bengbu Medical University
Conditions:
Internet Gaming Disorder
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
Internet Gaming Disorder (IGD) involves impaired cognitive control linked to reduced social reward and dACC-DLPFC brain circuit dysfunction. Enhancing social reward may restore this circuit and improv...
Detailed Description
Cognitive control decline is a key factor in the long-term persistence of Internet Gaming Disorder (IGD). The dorsal anterior cingulate cortex (dACC)-dorsolateral prefrontal cortex (DLPFC) circuit ser...
Eligibility Criteria
Inclusion
- Individuals aged between 18 and 35 years, irrespective of gender, having completed a minimum of 9 years of education and capable of effectively cooperating in questionnaire evaluations.
- Consent to actively cooperate in the completion of subsequent follow-up assessments.
- All are right-handed
- The Gaming Disorder Screening (GDSS) Scale score ≥ 47 points;
- The main game played is Honor of Kings; Average weekly gaming time (Honor of Kings) greater than 21 hours, maintained for over one year; More than 50% of daily internet time spent playing online games;
Exclusion
- Severe cognitive functional impairments manifested through a history of head trauma, cerebrovascular diseases, epilepsy, etc., or usage of cognitive enhancement drugs in the past 6 months; an intellectual disability with an IQ score less than 70.
- A diagnosis of schizophrenia or other severe mental illnesses as per the DSM-5 criteria.
- Abuse or dependence on other psychoactive substances (excluding nicotine) within the past 5 years.
- Severe organic diseases that might compromise study participation.
- Color blindness or color weakness
Key Trial Info
Start Date :
December 25 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 25 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06957392
Start Date
December 25 2024
End Date
December 25 2026
Last Update
May 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bengbu Medical University
Bengbu, China